• News

    In Memoriam: Olav Bjivoet, M.D.

    Date: September 17, 2014

    ASBMR is sad to announce the passing of honorary member Olav Bijvoet, M.D., an esteemed researcher who helped to lay the foundation of modern research in bone and mineral metabolism. As the first physician to treat the then untreatable Paget’s disease of bone with calcitonin, he recognized the potential of antiresorptive agents for treating bone disorders. He also discovered pamidronate, the first nitrogen-containing bisphosphonate (N-BP) and was the first to recognize the significance of the nitrogen atom present in the molecule of pamidronate for the potency and the different mechanism of action of N-BPs.

    Dr. Bijvoet actively promoted a multidisciplinary approach to research with specialists in the fields of endocrinology, nuclear medicine, oncology, radiology, pathology, rheumatology and urology.

    For his contribution to the care of patients with Paget’s disease, he received the first JB Johnson Award of the American Paget Foundation. He was also a co-founder of the Dutch Society for Calcium and Bone Metabolism and the first Editor of Clinical Research of Bone and Mineral, which later merged with Bone. Please feel free to share a kind note on the ASBMR Community page.